Alector, Inc. (ALEC) Covered Calls

You can sell covered calls on Alector, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ALEC (prices last updated Fri 4:16 PM ET):

Alector, Inc. (ALEC) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
5.25 +0.44 4.20 6.40 448K - 0.5
Covered Calls For Alector, Inc. (ALEC)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 5 0.30 6.10 -18.0% -298.6%
Jun 21 5 0.60 5.80 -13.8% -88.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in phase II clinical trial for the treatment of frontotemporal dementia disease; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002 and AL003, which are in phase 1b clinical trial for the treatment of Alzheimer's disease. In addition, it has 10 programs under research and development stage. The company has a collaboration agreement with Adimab, LLC for the research and development of antibodies. Alector, Inc. was founded in 2013 and is headquartered in South San Francisco, California.